As the world prepares for the 2024 Paris Olympics, a controversial alternative event is drawing sharp criticism from global sports authorities. The so-called 'Enhanced Games,' planned for late 2026 in the United States, has ignited fierce debate by openly encouraging athletes to use performance-enhancing drugs (PEDs).
The concept, backed by prominent financiers including a son of former U.S. President Donald Trump, claims to prioritize 'scientific exploration' through real-time monitoring of drug effects on athletes. However, the World Anti-Doping Agency (WADA) has condemned the event as dangerous and irresponsible, citing historical cases of athletes suffering permanent health damage or death from PED abuse.
China Anti-Doping Agency joined the chorus of disapproval, stating the competition distorts the essence of sport into a chemical arms race, directly contradicting global anti-doping efforts. Medical experts warn that normalizing PEDs could lead to catastrophic health consequences and undermine decades of athlete safety protocols.
Despite mounting opposition, organizers continue marketing the event as a new era of sports entertainment. The controversy raises critical questions about sports governance and corporate responsibility, with many fearing it could pressure vulnerable athletes into risking their health for financial gain.
As the 2026 date approaches, international sports bodies are urging governments and sponsors to reject the event. The outcome may set crucial precedents for maintaining ethical standards in global athletics.
